Vittoria Sykopetrites, Lahlou Ghizlene, Torres Renato, Daoudi Hannah, Mosnier Isabelle, Mazalaigue Stéphane, Ferrary Evelyne, Nguyen Yann, Sterkers Olivier
AP-HP, GHU Pitié-Salpêtrière, DMU ChIR, Service ORL, GRC Robotique et Innovation Chirurgicale, Sorbonne Université, Paris, France.
Inserm UMR 1120 "Innovative Technologies and Translational Therapeutics for Deafness", Hearing Institute Paris, Paris, France.
Eur Arch Otorhinolaryngol. 2021 Jan;278(1):77-85. doi: 10.1007/s00405-020-06070-z. Epub 2020 May 26.
Middle ear surgery may benefit from robot-based assistance to hold micro-instruments or an endoscope. However, the surgical gesture performed by one hand may perturb surgeons accustomed to two-handed surgery. A robot-based holder may combine the benefits from endoscopic exposure and a two-handed technique. Furthermore, tremor suppression and accurate tool control might help the surgeon during critical surgical steps. The goal of this work was to study the safety of an otological robot-based assistant under clinical conditions in a limited series of patients.
The RobOtol system has been used as an endoscope or a micro instrument holder for this series. Eleven cases were operated on with the robot as an endoscope holder for chronic otitis. Twenty-one cases were operated on with the robot as a micro-instrument holder for otosclerosis (9 cases), transtympanic tube placement (2 cases), or cochlear implantation (10 cases).
No complications related to the robot manipulation occurred during surgery nor in postoperative. In the chronic otitis group, all perforations were sealed and 3-month postoperative pure-tone average air-bone gap (PTA ABG) was 15 ± 2.6 dB. In the otosclerosis group, 1-month post-op PTA ABG was 10 ± 1 dB. For cochlear implantation cases, a scala tympani insertion, a vestibular scala translocation occurred and a full scala vestibuli insertion was observed in 7, 2 and 1 case, respectively.
The RobOtol system has reached the clinical stage. It could be used safely and with accurate control as an endoscope holder or a micro instrument holder in 32 cases.
中耳手术可能受益于基于机器人的辅助设备来握持微型器械或内窥镜。然而,单手进行的手术操作可能会使习惯双手手术的外科医生感到不适。基于机器人的握持器可能结合了内窥镜暴露和双手技术的优势。此外,震颤抑制和精确的工具控制可能在关键手术步骤中帮助外科医生。这项工作的目标是在有限数量的患者临床条件下研究基于耳科机器人的辅助设备的安全性。
在本系列研究中,RobOtol系统被用作内窥镜或微型器械握持器。11例慢性中耳炎患者使用机器人作为内窥镜握持器进行手术。21例患者使用机器人作为微型器械握持器进行手术,其中耳硬化症9例、经鼓膜置管2例、人工耳蜗植入10例。
手术期间及术后均未发生与机器人操作相关的并发症。在慢性中耳炎组,所有穿孔均已封闭,术后3个月纯音平均气骨导间距(PTA ABG)为15±2.6 dB。在耳硬化症组,术后1个月PTA ABG为10±1 dB。对于人工耳蜗植入病例,分别有7例、2例和1例观察到鼓阶插入、前庭阶移位和完全前庭阶插入。
RobOtol系统已进入临床阶段。它可以安全使用,并能精确控制,在32例手术中作为内窥镜握持器或微型器械握持器使用。